Ancora Advisors’s SCP & CO Healthcare Acquisition Company Warrant SHACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-18,668
Closed 2348
2022
Q3
$0 Hold
18,668
﹤0.01% 2439
2022
Q2
$1K Buy
18,668
+1,500
+9% +$209 ﹤0.01% 2203
2022
Q1
$4K Buy
17,168
+5,000
+41% +$1.93K ﹤0.01% 2048
2021
Q4
$7K Buy
12,168
+2,000
+20% +$1.18K ﹤0.01% 1948
2021
Q3
$6K Hold
10,168
﹤0.01% 1877
2021
Q2
$9K Buy
10,168
+5,168
+103% +$3.3K ﹤0.01% 1561
2021
Q1
$3K Buy
+5,000
New +$3.07K ﹤0.01% 1620

Ancora Advisors's SHACW Position: Q4 2022 in Review

Ancora Advisors sold out of SCP & CO Healthcare Acquisition Company Warrant (SHACW) in Q4 2022, closing a stake of 18,668 shares.

Ancora Advisors first reported a position in SHACW in Q1 2021 and held it in 7 quarters. The position peaked at $9K in Q2 2021. 0 funds tracked by Wall St. Rank hold SHACW as of Q4 2022.

  • Ancora Advisors reported no remaining SCP & CO Healthcare Acquisition Company Warrant position as of Q4 2022 after selling out during the quarter.
  • Ancora Advisors sold 18,668 SCP & CO Healthcare Acquisition Company Warrant shares in Q4 2022.
  • Ancora Advisors first reported a position in SCP & CO Healthcare Acquisition Company Warrant in Q1 2021 and held it in 7 quarters.
  • Ancora Advisors's SCP & CO Healthcare Acquisition Company Warrant position peaked at $9K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Warrant as of Q4 2022.

Based on Ancora Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.